Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population.

Journal Article (Journal)

Full Text

Duke Authors

Cited Authors

  • Richardson, PG; Warren, DL; Momtaz, P; Soiffer, R; Antin, JH; Spitzer, T; Avigan, D; Wei, LJ; Jin, Z; Rifai, N; Bradwin, G; Vredenburgh, J; Kurtzberg, J; Martin, PL; Vogelsang, G; Arai, S; Chen, A; McDonald, GB; Murray, K; Iacobelli, M; Guinan, EC

Published Date

  • November 16, 2001

Published In

Volume / Issue

  • 98 / 11

Start / End Page

  • 853A - 853A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971


  • English